NCT04133324

Brief Summary

The aim of this study is to investigate the diagnostic accuracy of the C Protein Reactive (CRP) for the detection of Anastomotic leakage after surgery for digestive cancer. The standard protocol in our unit is to measure the CRP on the second and fourth postoperative day. The main aim of the study is to investigate the diagnostic accuracy of the ratio CRP on the fourth postoperative day on CRP on the second postoperative day (CRP\_D4/CRP\_D2). Secondary outcomes are the diagnosis accuracy of the CRP\_D4 and CRP\_D2.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 21, 2019

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 6, 2022

Status Verified

April 1, 2022

Enrollment Period

5.8 years

First QC Date

October 17, 2019

Last Update Submit

April 4, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • CRP_D4/CRP_D2

    Diagnosis accuracy of the ratio CRP at the fourth on the second postoperative day after surgical resection for digestive cancer, using the receiving operating curve, sensibility, specificity, positive predictive value, and negative predictive value.

    30 days after surgery

  • CRP_D4/CRP_D2 Colorectal

    Diagnosis accuracy of the ratio CRP at the fourth on the second postoperative day after surgical resection for colorectal cancer, using the receiving operating curve, sensibility, specificity, positive predictive value, and negative predictive value.

    30 days after surgery

Secondary Outcomes (4)

  • CRP_D4

    30 days after surgery

  • CRP_D4 colorectal

    30 days after surgery

  • CRP_D2

    30 days after surgery

  • CRP_D2 colorectal

    30 days after surgery

Study Arms (1)

Main group

One groupe in the study

Diagnostic Test: C-reactive protein

Interventions

C-reactive proteinDIAGNOSTIC_TEST

C-reactive protein at postoperative days four and two.

Main group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consecutive patients who will undergo surgical resection for digestive cancer with the creation of anastomosis will be included. The standard protocol in our unit is to measure the CRP at the second and fourth postoperative days for early detection of anastomotic leakage. The following information will be recorded: age, gender, type of surgery, type of anastomosis, postoperative morbidity according to Clavien Grade, anastomotic leakage occurrence, infectious complications.

You may qualify if:

  • Surgical resection for digestive cancer
  • Creation of anastomosis.
  • at least one measurement of CRP at the second and/or fourth postoperative day.

You may not qualify if:

  • Surgical resection without anastomosis creation
  • No measurement of CRP on the second or the fourth postoperative day.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Oncology

Rabat, 10090, Morocco

RECRUITING

MeSH Terms

Conditions

Anastomotic LeakDigestive System Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsDigestive System Diseases

Study Officials

  • Anass Majbar, MD

    National Institute of Oncology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study investigator

Study Record Dates

First Submitted

October 17, 2019

First Posted

October 21, 2019

Study Start

April 1, 2018

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

April 6, 2022

Record last verified: 2022-04

Locations